Skip to main content
. Author manuscript; available in PMC: 2014 Jan 28.
Published in final edited form as: Am J Hematol. 2012 Aug 7;87(11):1017–1021. doi: 10.1002/ajh.23306

Table IIB. Most common adverse events, occurring in 10% or more of subjects.

Event HQK-1001
(n = 20, all doses)
% of subjects		 Placebo
(n = 4)
% of subjects
Sickle cell crisis 45 75
Nausea 30 25
Pain in extremity 30 0
Cough 30 0
Arthalgia 25 25
Headache 25 25
Chest Pain 15 25
URI 15 25
Back Pain 15 25
Vomiting 15 0